Pediatrix Medical Group, Inc. (NYSE: MD) Stock Analysis & Fundamentals

MDPediatrix Medical Group, Inc.

NYSE · US · Healthcare · Medical Care Facilities · pediatrix.com

26.34USD+1.78%Mkt Cap: 2.16B $P/E: 12.791d ago

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born premat…

Headline	Source	Time
Today
Is Pediatrix Medical Group (MD) Overvalued As It Reaffirms Its 2026 EBITDA Outlook? Pediatrix Medical Group (MD) drew fresh investor attention after updating second quarter business trends, highlighting a stable payor mix and reaffirming its full year 2026 Adjusted EBITDA outlook of $280 million to $300 million. See our latest analysis for Pediatrix Medical Group. Pediatrix Medical Group’s recent update on stable business trends comes after a strong run, with a year to date share price return of 23.72% and a 1 year total shareholder return of 105.14%. The latest 1 day move...	Simply Wall St.	15h
Yesterday
Stable Payor Mix And Reaffirmed Outlook Might Change The Case For Investing In Pediatrix (MD) Pediatrix Medical Group recently reported that its second-quarter 2026 payor mix and other net revenue-related trends remained stable and in line with recent history and internal expectations, while also reaffirming its full-year 2026 Adjusted EBITDA outlook of US$280 million to US$300 million. This confirmation of steady reimbursement patterns and earnings guidance, at a time when many healthcare peers report pressure on payor mix and utilization, highlights Pediatrix’s relatively resilient...	Simply Wall St.	21h
Pediatrix Medical Group (MD) Soars 7.3%: Is Further Upside Left in the Stock? Pediatrix Medical Group (MD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.	Zacks	1d
This week
ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues Elevance Health beats Q2 EPS and revenue estimates, raises 2026 adjusted EPS outlook despite lower earnings, softer membership and higher expenses.	Zacks	2d
Older
Can Elevance Recover $115 Million Through Its CMS Lawsuit?	Zacks	Jul 3
3 Unpopular Stocks That Concern Us	StockStory	Jul 3
3 Profitable Stocks Walking a Fine Line	StockStory	Jun 29
3 Russell 2000 Stocks with Warning Signs	StockStory	Jun 26
3 Hyped Up Stocks with Open Questions	StockStory	Jun 22
MOH Wins Illinois Medicaid Contract, Reinforcing Long-Term Stability	Zacks	Jun 12
Humana Closes the Kindred Chapter With $900 Million Gentiva Exit	Zacks	Jun 11
Brookdale Senior May 2026 Occupancy Volume Rises to 82.5%	Zacks	Jun 9
Why Is Pediatrix Medical Group (MD) Down 1.7% Since Last Earnings Report?	Zacks	Jun 4
Q1 Earnings Roundup: Pediatrix Medical Group (NYSE:MD) And The Rest Of The Healthcare Providers & Services Segment	StockStory	Jun 1
Assessing Pediatrix Medical Group (MD) Valuation As Shares Show Mixed Short Term Momentum	Simply Wall St.	Jun 1
Does Pediatrix Medical Group (MD) Stock Look Better After Q1 Report?	Insider Monkey	May 27
Broad-Based MedSurg Growth Likely to Aid MDT's Q4 Performance	Zacks	May 26
3 Stocks Under $50 with Questionable Fundamentals	StockStory	May 22
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock	Zacks	May 21
How Investors Are Reacting To Pediatrix Medical Group (MD) Pricing‑Driven Earnings Outperformance And Margin Gains	Simply Wall St.	May 18
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now	Zacks	May 15
The 5 Most Interesting Analyst Questions From Pediatrix Medical Group’s Q1 Earnings Call	StockStory	May 15
Mizuho Lifts PT on Pediatrix Medical Group (MD) Following Q1 Results	Insider Monkey	May 14
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term	Zacks	May 14
Pediatrix. (MD) Reports Q1 EPS Beat	Insider Monkey	May 13

Industry Peers